DeepMed Research

K-777

Generic Name: K-777

Drug Type: Small Molecule

Chemical Formula: C_₃₂H_₃₈N_₄O_₄S

CAS Number: 502960-90-9

Unique Ingredient Identifier: 320A4L58IZ

Clinical Trials

Safety Study of SLV213 for the Treatment of COVID-19.

Phase 1

Terminated

Conditions: COVID-19

Interventions: Other: Placebo for SLV213
Drug: SLV213

First Posted Date: 2023-11-24

Last Posted Date: 2024-10-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 16

Registration Number: NCT06146374

Locations: 🇺🇸
Altasciences Inc - Kansas City, Overland Park, Kansas, United States

SLV213 Treatment in Ambulatory COVID-19 Patients

Phase 2

Not yet recruiting

Conditions: Covid19

Interventions: Drug: Placebo
Drug: SLV213

First Posted Date: 2021-04-14

Last Posted Date: 2023-04-12

Lead Sponsor: Kenneth Krantz, MD, PhD

Target Recruit Count: 81

Registration Number: NCT04843787

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy